Annual SGA
$108.70 M
+$63.75 M+141.83%
December 31, 2023
Summary
- As of February 12, 2025, TARS annual SGA is $108.70 million, with the most recent change of +$63.75 million (+141.83%) on December 31, 2023.
- During the last 3 years, TARS annual SGA has risen by +$100.53 million (+1230.15%).
- TARS annual SGA is now at all-time high.
Performance
TARS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$57.91 M
-$882.00 K-1.50%
September 30, 2024
Summary
- As of February 12, 2025, TARS quarterly SGA is $57.91 million, with the most recent change of -$882.00 thousand (-1.50%) on September 30, 2024.
- Over the past year, TARS quarterly SGA has increased by +$14.90 million (+34.66%).
- TARS quarterly SGA is now -1.50% below its all-time high of $58.79 million, reached on June 30, 2024.
Performance
TARS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.18 B
-$134.34 M-12.90%
September 30, 2024
Summary
- As of February 12, 2025, TARS TTM SGA is -$1.18 billion, with the most recent change of -$134.34 million (-12.90%) on September 30, 2024.
- Over the past year, TARS TTM SGA has dropped by -$1.28 billion (-1181.71%).
- TARS TTM SGA is now -19386.53% below its all-time high of -$6.03 million.
Performance
TARS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TARS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +141.8% | +34.7% | -1181.7% |
| 3 y3 years | +1230.2% | +34.7% | -1181.7% |
| 5 y5 years | +10000.0% | +34.7% | -1181.7% |
TARS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +328.0% | -1.5% | +755.1% | -904.2% | at low |
| 5 y | 5-year | at high | +9468.7% | -1.5% | >+9999.0% | <-9999.0% | at low |
| alltime | all time | at high | >+9999.0% | -1.5% | >+9999.0% | <-9999.0% | at low |
Tarsus Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $57.91 M(-1.5%) | $211.28 M(+15.0%) |
| Jun 2024 | - | $58.79 M(+14.0%) | $183.70 M(+26.5%) |
| Mar 2024 | - | $51.58 M(+19.9%) | $145.18 M(+33.6%) |
| Dec 2023 | $108.70 M(+141.8%) | $43.01 M(+41.8%) | $108.70 M(+35.3%) |
| Sep 2023 | - | $30.32 M(+49.6%) | $80.33 M(+29.6%) |
| Jun 2023 | - | $20.27 M(+34.3%) | $62.00 M(+19.0%) |
| Mar 2023 | - | $15.10 M(+3.2%) | $52.10 M(+15.9%) |
| Dec 2022 | $44.95 M(+77.0%) | $14.63 M(+22.0%) | $44.95 M(+21.2%) |
| Sep 2022 | - | $11.99 M(+15.6%) | $37.09 M(+16.8%) |
| Jun 2022 | - | $10.38 M(+30.6%) | $31.77 M(+12.7%) |
| Mar 2022 | - | $7.95 M(+17.3%) | $28.18 M(+11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $25.40 M(+210.8%) | $6.77 M(+1.5%) | $25.40 M(+12.8%) |
| Sep 2021 | - | $6.67 M(-1.8%) | $22.52 M(+25.1%) |
| Jun 2021 | - | $6.79 M(+31.7%) | $17.99 M(+41.4%) |
| Mar 2021 | - | $5.16 M(+32.6%) | $12.73 M(+55.7%) |
| Dec 2020 | $8.17 M(+619.4%) | $3.89 M(+80.9%) | $8.17 M(+75.0%) |
| Sep 2020 | - | $2.15 M(+40.9%) | $4.67 M(+69.6%) |
| Jun 2020 | - | $1.53 M(+151.8%) | $2.75 M(+124.4%) |
| Mar 2020 | - | $606.00 K(+56.6%) | $1.23 M(+97.6%) |
| Dec 2019 | $1.14 M(+153.0%) | $387.00 K(+65.4%) | $621.00 K(+165.4%) |
| Sep 2019 | - | $234.00 K | $234.00 K |
| Dec 2018 | $449.00 K | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual SGA year-on-year change?
- What is Tarsus Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly SGA year-on-year change?
- What is Tarsus Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM SGA year-on-year change?
What is Tarsus Pharmaceuticals annual SGA?
The current annual SGA of TARS is $108.70 M
What is the all time high annual SGA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual SGA is $108.70 M
What is Tarsus Pharmaceuticals annual SGA year-on-year change?
Over the past year, TARS annual SGA has changed by +$63.75 M (+141.83%)
What is Tarsus Pharmaceuticals quarterly SGA?
The current quarterly SGA of TARS is $57.91 M
What is the all time high quarterly SGA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly SGA is $58.79 M
What is Tarsus Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, TARS quarterly SGA has changed by +$14.90 M (+34.66%)
What is Tarsus Pharmaceuticals TTM SGA?
The current TTM SGA of TARS is -$1.18 B
What is the all time high TTM SGA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM SGA is -$6.03 M
What is Tarsus Pharmaceuticals TTM SGA year-on-year change?
Over the past year, TARS TTM SGA has changed by -$1.28 B (-1181.71%)